Transcriptomic results suggested that TIIA plays a role through the PPAR pathway, and our study confirmed that TIIA may play an anti-NASH role by regulating PPARα, but we did not confirm whether it also plays a role through PPARβ/δ and PPARγ. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.